Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neoplasms by Site × spartalizumab × 30 days × Clear all

Sponsor

Conditions

Uterine Cervical Neoplasms 2 Carcinoma, Renal Cell 2 von Hippel-Lindau Disease 1 Solid Tumors 1 Prostatic Neoplasms 1 Pheochromocytoma 1 Paraganglioma 1 Hereditary leiomyomatosis and renal cell cancer 1 Glioma 1 Endometrial Neoplasms 1 Diffuse Intrinsic Pontine Glioma 1

Interventions

durvalumab 3 Fulvestrant 3 Carboplatin 3 pembrolizumab 2 Pemetrexed 2 Cisplatin 2 trametinib 1 ribociclib 1 pralsetinib 1 palbociclib 1 exemestane 1 darolutamide 1 dabrafenib 1 ceralasertib 1 STX-478 1 Paclitaxel 1 Letrozole 1 Immunotherapy 1 Gemcitabine 1 Cetuximab 1 Anastrozole 1 2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 1 130-nm albumin-bound paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡